ascenion
clear

 

Ascenion's Results

In 2008, Ascenion supported 73 patent applications, mediated 71 agreements with industry and closed 4 spin-off deals. About EUR 2.5 million were earned for Ascenion‘s partner institutions, including revenues from licence, cooperation and material transfer agreements as well as proceeds from equity deals and partial operational profits of Ascenion thatwere passed on to the Life-Science Foundation.

Meet us at the forthcoming events:

STS Forum, October 4–6, 2009, Kyoto, Japan

ASTP Fall Seminar, October 29 & 30, 2009, Krakow, Poland

BioEurope, November 2–4, 2009, Vienna, Austria 

Biotech Networkshop, February 24–26, 2010, Schloss Ringberg (Tegernsee),  Germany

BioVaria, April 20, 2010, Munich, Germany

News in Brief:

Partnership with nine Leibniz Institutes continued
Following 3 years of collaboration, all the partner institutions of the Leibniz Association decided to continue their cooperation with Ascenion as exclusive marketing partner.
 more

 
New partner from the Leibniz Association: IfN
Ascenion has also closed a partnership contract with the Leibniz Institute for Neurobiology (IfN) in Magdeburg. more


Alliance with TWINCORE 
Ascenion and TWINCORE - Centre for Experimental and Clinical Infection Research, Hanover, have signed an exclusive collaboration agreement for comprehensive IP asset management support. more


New assistant for Ascenion’s team
Since January this year, Christiane Schwarz has been assisting Ascenion’s management and co-ordinates travel for all her colleagues more


Rights to new ALL-test licensed to Medac
Ascenion has initiated and negotiated a licence agreement on behalf of Hanover Medical School (MHH) providing Medac with exclusive worldwide rights to a diagnostic test that can help guide the treatment of acute lymphoblastic leukemia (ALL). more


Fast diagnosis of cardiovascular diseases: Licence agreement with Roche Diagnostics
Researchers at the MHH Hospital for Cardiology and Angiology around Prof. Dr Kai C. Wollert have identified growth-differentiation factor-15 (GDF-15) as a marker in the blood of cardiac patients
more


Novel antibiotic against tuberculosis licensed to Inverness Medical
Ascenion has negotiated the agreement on behalf of an international consortium of patent owners including a Russian inventor, the Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institute (HKI) and the Institut Pasteur. more


FZB closes four collaboration contracts 
The FZB - Research Center Borstel - Leibniz Center for Medicine and Biosciences has entered into four alliances with industry:
more


DIfE becomes member of the Life Science Foundation
Ascenion’s parent holding, the Life Science Foundation for the Promotion of Science and Research has a new member: the Institute of Human Nutrition (DifE).
more


Contact us:

Munich:
T +49 89 318814-0
info(at)ascenion.de

Berlin:
T +49 30 9406 230 -1/-4
berlin(at)ascenion.de

Braunschweig:
T +49 531 6181 2090
braunschweig(at)ascenion.de

Hamburg:
T +49 40 22611 278
habeck(at)ascenion.de

Hanover:
T +49 511 5328 921
cordes(at)ascenion.de

Neuherberg:
T +49 89 3187 2850
scheek(at)ascenion.de

Ascenion GmbH, www.ascenion.de